University of Nottingham ranked in the world's top 100 universities
Professor Jane Norman, President and Vice-Chancellor of the University of Nottingham, said: 'We are proud to be ranked among the top 100 universities in the world, this is testament to the dedication and excellence of colleagues who provide world-class education, deliver outstanding research, and support our graduates to achieve their career ambitions.
The QS World University Rankings evaluate hundreds of universities globally using six key performance indicators that assess research, teaching, employability, reputation, sustainability and internationalisation. The methodology relies on global surveys focusing on academic reputation and employer reputation.
READ MORE: The landmark buildings set to be demolished under Nottingham Forest's City Ground plans
READ MORE: 'I live in Nottingham tower endangered by construction defects - please crack on with fixing it'
Nottingham performed strongly for employability and employer reputation, reflecting its position as the UK's leading university for graduates entering highly skilled employment and 3rd in the UK for university's targeted by top employers.
The richness and diversity of the university's international research partnerships also played a key role in its placement in this year's ranking, recognising the role that Nottingham's research plays in changing lives and finding solutions to global challenges.
Nottingham is known internationally as the birthplace of MRI and for its work driving advances in cancer treatment and pharmacy and discovering new insights into virology.
The university has the world's largest group of researchers dedicated to ending modern day slavery by 2030 through evidence-based strategies and global collaboration and its experts are helping to tackle climate change by accelerating green technology innovations to achieve a zero-carbon future.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 hours ago
- Yahoo
What are the symptoms of the new Stratus COVID variant?
Cases of a new COVID variant have been reported in the UK. The strain has been dubbed 'Stratus' and there are two variants in circulation – XFG and the spin-off XFG.3 According to the UK Health Security Agency (UKHSA), Stratus variants currently account for just over 30% of COVID cases in England, up from 10% in May. The World Health Organization (WHO) has said that XFG is growing rapidly globally and is thought to be slightly more infectious than previous variants. However, experts suggest there is no need to be unduly worried. The UKHSA says Stratus does not appear to pose any greater risk to health than other strains, and COVID cases in general are decreasing compared to recent weeks. "Based on the available information so far, there is no evidence to suggest that the XFG and XFG.3 variants cause more severe disease than previous variants, or that the vaccines in current use will be less effective against them," Dr Alex Allen, consultant epidemiologist at the UKHSA, told Yahoo UK. "It is normal for viruses to mutate and change over time. UKHSA is monitoring all available data relating to SARS-CoV-2 variants in the UK and abroad, and we continue to publish our findings in our regular Flu and COVID-19 surveillance reports." Stratus is a descendant of the Omicron COVID variant. It is a recombinant strain, sometimes called a 'Frankenstein' strain. This means it emerged when a person was infected with two COVID variants at once, creating a new hybrid variant. XFG has been declared a 'variant under monitoring' by the WHO, meaning health authorities across the world have been asked to help track it to determine any public health implications. However, while the variant is said to spread rapidly, the WHO has classed it as 'low risk' on a global level. There isn't enough evidence yet to suggest this strain has any symptoms that might differentiate it from others. However, one doctor said that, while symptoms vary from person to person, the Stratus variant may be associated with hoarseness. 'One of the most noticeable symptoms of the Stratus variant is hoarseness, which includes a scratchy or raspy voice," Dr Kaywaan Khan, Harley Street GP and Founder of Hannah London Clinic, told Cosmopolitan. "Regardless of whether the symptoms mimic a cold or flu, testing continues to be the critical step in eliminating the possibility of a coronavirus infection," he added. According to the NHS, common symptoms of COVID can include: a high temperature or shivering a new, continuous cough a loss or change to your sense of smell or taste shortness of breath Feelings of fatigue or exhaustion aches headache sore throat blocked or runny nose loss of appetite diarrhoea feeling sick or vomiting The UKHSA says that "COVID-19 activity decreased across most indicators" in the week ending 29 June and was at baseline levels. COVID hospital admissions in England dropped to 0.99 per 100,000 compared to 1.46 the week before. And the number of people tested in GP surgeries who returned positive results fell to 7.8% from 8.8%. Hundreds of events mark five years since Covid-19 outbreak (The Guardian, 3-min read) What are the symptoms of the Nimbus COVID variant? (Yahoo Life UK, 3-min read) Public trust in science has been eroded, from Covid-19 to climate (The Guardian, 3-min read)
Health Line
11 hours ago
- Health Line
What We Know About CBD for Macular Degeneration (AMD)
CBD has similar pain-relieving effects to THC but isn't psychoactive. Early research suggests CBD may help AMD, but it is not endorsed by doctors. Age-related macular degeneration (AMD) is a leading cause of vision loss in the United States, with age and family being primary risk factors. While healthcare professionals do not currently recommend cannabis and CBD as a treatment option for macular degeneration or other eye health issues, ongoing research suggests it may one day be a possible treatment option for some people with this eye condition. Do CBD treatments help with macular degeneration? About macular degeneration treatments There are two kinds of age-related macular degeneration. Dry AMD is more common. Treatment for dry AMD includes taking specific nutritional supplements and using low-vision aids. Wet AMD is not as common, but it's more treatable. Treatments include anti-vascular endothelial growth factor (VEGF) eye injections and light therapy. Generally, cannabis use is linked to lowered eye pressure and is known to help lower inflammation throughout the body. Some people with AMD have reported anecdotal benefits from CBD use. This 2022 research in the United Kingdom (IK) does indicate that CBD may possibly lower the risk of this eye condition. However, there's not enough medical research overall to support CBD as a treatment for any type of AMD. In the UK study looking at people who'd used marijuana (including CBD) more than 100 times, they did see a lower risk for AMD. But the research also indicated people experienced higher rates of blood vessel loss, possibly leading to AMD development sooner for younger people. Research on this topic has also found that many forms of CBD can't be easily administered as treatments for eye conditions. For instance, CBD oils aren't the right consistency to be made into eye drops. Can you use CBD for other eye conditions? CBD is known to have an effect on eye pressure, which could be a meaningful benefit for acute or chronic eye conditions. For example, glaucoma is an eye condition that can lead to permanent vision loss, but it has a different cause than AMD. It's often caused by a buildup of eye pressure on your optic nerve (it sends visual information from your eyes to your brain). Lowering eye pressure could potentially lower the risk of glaucoma and help treat active cases. But research is conflicting and shows there may also be side effects of using CBD for glaucoma or other eye conditions, including mental health concerns, vision changes such as color blindness, retinal deterioration, and optic nerve damage. No enough research exists to support CBD as a treatment for eye pressure or as a way to lower the risk of either glaucoma or AMD. Results are conflicting. A 2018 study found that CBD (cannabidiol) eye drops increased eye pressure in rats. But the same study found that THC (tetrahydrocannabinol) eye drops reduced eye pressure by up to 30%. Treatment of AMD and glaucoma isn't the only possible eye-health-related use of CBD. Research is also being done into the use of CBD to help treat: diabetic retinopathy eye inflammation corneal inflammation eye pain Additional research is needed to determine if CBD or THC could be used in glaucoma or AMD treatment and prevention. Right now neither is approved for managing these conditions. Traditional AMD treatments Traditional, scientifically backed AMD treatment regimens depend on the type of AMD you have. They may include. Anti-VEGF injections: These injections are the most common treatment for wet AMD. They stop the growth of eye blood vessels and can prevent and possibly reverse vision loss. Light therapy: Known as photodynamic therapy, this treatment type may also be used to target and destroy blood vessels. Nutritional supplements: A combination of nutritional supplements known as the AREDS2 formula has been shown to help prevent further vision loss due to dry AMD. However, these supplements aren't proven to lower the chance of AMD onset overall. Low vision aids: These can help with any vision loss you experience due to either form of AMD or another condition. They are an essential tool in managing dry AMD. An eye doctor can help you determine the best options for you. Options may include wearing glasses, using a magnifying glass, large print materials, and an array of computer programs or mobile apps. How can you prevent macular degeneration? AMD is tied to multiple risk factors, many of which you can't control including age and genetics passed down through families. However, you can practice habits to support good eye health, which benefits your eyes lifelong. These may include: Getting regular eye exams. Don't smoke or quit smoking. Getting regular physical activity. Eating certain foods that may help your eye health, including low cholesterol foods.
Yahoo
15 hours ago
- Yahoo
Scientists launch controversial project to create the world's first artificial human DNA
[Source] Researchers at five British universities have launched the Synthetic Human Genome Project (SynHG) with an initial grant of approximately $12.6 million from Wellcome, the U.K.'s largest biomedical research charity. Unveiled on Thursday, the five-year effort is led by molecular biologist Jason W. Chin at the Medical Research Council Laboratory of Molecular Biology in Cambridge and aims to assemble an entire human chromosome, base by base, inside the lab. Writing a genome Instead of tweaking existing DNA with tools such as CRISPR, SynHG will attempt to 'write' long stretches of code before inserting them into cultured human skin cells to study how chromosome architecture drives health and disease. The project builds on Chin's earlier success constructing a fully synthetic E. coli genome. The laboratory playbook blends generative-AI sequence design with high-throughput robotic assembly, allowing scientists to plan and assemble millions of DNA bases. Patrick Yizhi Cai of the University of Manchester, who oversees these methods, says the approach 'leverag[es] cutting-edge generative AI and advanced robotic assembly technologies to revolutionize synthetic mammalian chromosome engineering.' Trending on NextShark: Why experts are cautious Geneticist Robin Lovell-Badge of London's Francis Crick Institute emphasized the importance of understanding not only the scientific potential but also the societal values and risks involved. He warned that as research progresses, there is the possibility of creating synthetic cells that could, if used in humans, lead to tumors or produce novel infectious particles if not carefully designed. Lovell-Badge recommended that any engineered cells should include safeguards, such as inducible genetic kill switches, to ensure they can be eliminated from the body or targeted by the immune system if needed. Sarah Norcross, director of the Progress Educational Trust, echoed the need for transparency and public engagement, highlighting that synthesizing human genomes is controversial and requires researchers and the public to be in active communication. Norcross welcomed the project's built-in social science program, which surveys communities across Asia-Pacific, Africa, Europe and the Americas as the science unfolds and is led by social scientist Joy Yueyue Zhang, as a way to ensure that public interests and concerns are considered from the outset. Trending on NextShark: Road ahead Over the next five years, the consortium will iterate design–build–test cycles, aiming first for an error-free synthetic chromosome representing roughly 2% of human DNA. Alongside the laboratory milestones, the team plans to release an open-access toolkit covering both the technical and governance lessons learned. Trending on NextShark: This story is part of The Rebel Yellow Newsletter — a bold weekly newsletter from the creators of NextShark, reclaiming our stories and celebrating Asian American voices. Subscribe free to join the movement. If you love what we're building, consider becoming a paid member — your support helps us grow our team, investigate impactful stories, and uplift our community. ! Trending on NextShark: Download the NextShark App: Want to keep up to date on Asian American News? Download the NextShark App today!
